This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
marijuana: Archive
TLRY Stock Loses 38% in a Month: Should You Buy the Dip?
by Sundeep Ganoria
Tilray's slump deepens as a tighter U.S. hemp rule and a reverse split stir uncertainty despite gains in global cannabis sales.
CGCNegative Net Change TLRYPositive Net Change CURLFPositive Net Change
marijuana medical
Tilray Brands Strengthens Domestic Lead With Strong Q1 Cannabis Growth
by Sridatri Sarkar
TLRY posts a strong quarter as Canadian cannabis revenues grow and market shares climb across key product categories.
CGCNegative Net Change TLRYPositive Net Change CRLBFNegative Net Change
marijuana medical
Why Jazz Pharmaceuticals May Be a Stealth Cannabis Winner
by Sundeep Ganoria
JAZZ leverages Epidiolex's rising sales and its broad drug portfolio to strengthen its position in the evolving medical cannabis market.
JAZZPositive Net Change TLRYPositive Net Change VRNONegative Net Change
biotechs marijuana medical pot-stocks
TLRY vs. CRLBF: Which Cannabis Player Offers Greater Upside?
by Sridatri Sarkar
Tilray Brands' global expansion and strong Canadian momentum spotlight its edge as investors weigh upside against Cresco Labs' slower growth.
TLRYPositive Net Change CRLBFNegative Net Change
marijuana medical
Cresco Labs Expands Operations Beyond U.S.: How to Play the Stock?
by Sundeep Ganoria
CRLBF's move into Germany opens a new growth path as it navigates U.S. pricing pressure and rising competition in its core market.
CGCNegative Net Change TLRYPositive Net Change CRLBFNegative Net Change CURLFPositive Net Change
marijuana medical
Tilray Brands Extends Profit Momentum With Strong Q1 Results
by Sridatri Sarkar
TLRY posts a sharp profitability turnaround in Q1 as cost control, efficiency gains and portfolio optimization boost results.
TLRYPositive Net Change ACBPositive Net Change VRNONegative Net Change
marijuana medical
Should You Buy, Hold or Sell CGC Stock Post Q2 Earnings Release?
by Sundeep Ganoria
Canopy Growth's narrower loss, rising Canadian sales and improving margins signal progress in its turnaround, even as competition and global headwinds persist.
CGCNegative Net Change TLRYPositive Net Change ACBPositive Net Change CURLFPositive Net Change
marijuana medical
Tilray Brands Extends Global Reach With Key Approvals and Launches
by Sridatri Sarkar
TLRY expands its global medical cannabis footprint with key launches and approvals across Panama, Germany, Italy and Australia.
TLRYPositive Net Change VFFNegative Net Change CURLFPositive Net Change
marijuana
Cannabis Stock Tilray Brands Skyrockets 94.5%: Time to Buy, Sell or Hold?
by Sridatri Sarkar
TLRY's 94.5% surge, record fiscal Q1 revenues, and expanding medical cannabis footprint fuel optimism amid global challenges.
TLRYPositive Net Change VFFNegative Net Change CURLFPositive Net Change
marijuana medical
Should You Buy, Hold or Sell VRNO Stock Post Q3 Earnings Release?
by Sundeep Ganoria
Verano's Q3 results show pressure from U.S. price competition and margin compression, but cost cuts and new products signal longer-term optimism.
CGCNegative Net Change TLRYPositive Net Change GTBIFNegative Net Change VRNONegative Net Change
marijuana medical
Cannabis Stock VFF Soars Over 300% YTD: Time to Buy, Sell or Hold?
by Sundeep Ganoria
Village Farms' surge reflects its pivot to a pure-play cannabis model, record profitability and a confident $10M share buyback.
TLRYPositive Net Change VFFNegative Net Change CURLFPositive Net Change
marijuana medical
How to Play Aurora Cannabis Stock Amid Renewed Legalization Hopes?
by Sundeep Ganoria
Aurora Cannabis gains 21% as its medical segment fuels revenue and margin growth, even as recreational sales drag.
TLRYPositive Net Change ACBPositive Net Change CURLFPositive Net Change
marijuana medical
Should You Buy TLRY Stock After Encouraging Q1 Results?
by Sundeep Ganoria
Tilray's return to profitability, stronger cash flow, and expanding global cannabis and beverage operations highlight its renewed growth story.
CGCNegative Net Change TLRYPositive Net Change ACBPositive Net Change CURLFPositive Net Change
marijuana medical
Should You Buy or Sell CURLF Stock Amid Renewed Legalization Hopes?
by Sundeep Ganoria
Curaleaf's shares have soared over 200% on renewed legalization optimism, but domestic weakness and profit hurdles cloud the outlook.
CGCNegative Net Change TLRYPositive Net Change ACBPositive Net Change CURLFPositive Net Change
marijuana medical
From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects
by Aparajita Dutta
Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism.
MJNegative Net Change TLRYPositive Net Change YOLONegative Net Change CNBSNegative Net Change MSOSNegative Net Change WEEDNegative Net Change
marijuana
Trump's CBD Video Sparks Buzz: 3 Cannabis Stocks to Watch
by Sundeep Ganoria
Trump's CBD video fuels momentum in cannabis, with Village Farms, Canopy Growth, and Tilray emerging as stocks to watch in 2025.
CGCNegative Net Change TLRYPositive Net Change VFFNegative Net Change
marijuana medical
Here's Why JAZZ Stock Is an Unconventional Cannabis Investment
by Sundeep Ganoria
Jazz Pharma is redefining cannabis investing with Epidiolex, a fast-growing FDA-approved epilepsy drug fueling its growth.
JAZZPositive Net Change ACBPositive Net Change GTBIFNegative Net Change
biotechs marijuana medical
Green Thumb Launches $50M Buyback: Time to Get Bullish on the Stock?
by Sundeep Ganoria
GTBIF launches a $50 million share buyback program, signaling confidence in long-term growth despite market and pricing pressures.
TLRYPositive Net Change GTBIFNegative Net Change CURLFPositive Net Change
marijuana medical
Cannabis Stock CRLBF Gains 25% in a Month: Time to Buy, Sell or Hold?
by Sundeep Ganoria
CRLBF surges 25% this month on reform hopes, but revenue declines, margin pressure and stiff competition cloud its outlook.
TLRYPositive Net Change GTBIFNegative Net Change CRLBFNegative Net Change CURLFPositive Net Change
marijuana
Cannabis Stock CRON Trades Near 52-Week High: How to Play
by Sundeep Ganoria
Cronos trades near its 52-week high as international growth boosts sales, but losses and stiff competition weigh on its outlook.
CRONNo Net Change TLRYPositive Net Change HITINegative Net Change CURLFPositive Net Change
marijuana medical
Cannabis Stock VRNOF Soars 178% in a Month: Time to Buy, Sell or Hold?
by Sundeep Ganoria
Verano's stock has surged 178% in a month on reform hopes, but pricing pressure and stiff competition test its momentum.
ACBPositive Net Change GTBIFNegative Net Change CURLFPositive Net Change
marijuana medical
3 Cannabis Stocks to Watch After Trump's Marijuana Rescheduling Signal
by Sundeep Ganoria
Trump's marijuana rescheduling remarks reignite cannabis optimism, putting Village Farms, Canopy Growth and High Tide in focus.
CGCNegative Net Change VFFNegative Net Change HITINegative Net Change
marijuana medical pot-stocks
Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification
by Sweta Killa
Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.
MJNegative Net Change CGCNegative Net Change TLRYPositive Net Change ACBPositive Net Change YOLONegative Net Change CNBSNegative Net Change MSOSNegative Net Change WEEDNegative Net Change
etfs marijuana
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
by Sundeep Ganoria
Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.
CRBPNegative Net Change CGCNegative Net Change TLRYPositive Net Change HRMYPositive Net Change GTBIFNegative Net Change
biotechs marijuana medical pot-stocks
Should You Buy, Hold or Sell TLRY Stock Post Q4 Earnings Release?
by Sundeep Ganoria
Tilray posts record non-cannabis revenues in fiscal 2025, but Q4 sales slip as cannabis weakness pressures overall results.
CGCNegative Net Change TLRYPositive Net Change ACBPositive Net Change CURLFPositive Net Change
earnings marijuana medical pot-stocks